ES2912785T3 - Catéteres ureterales y vesicales y métodos de inducción de presión negativa para aumentar la perfusión renal - Google Patents
Catéteres ureterales y vesicales y métodos de inducción de presión negativa para aumentar la perfusión renal Download PDFInfo
- Publication number
- ES2912785T3 ES2912785T3 ES18791406T ES18791406T ES2912785T3 ES 2912785 T3 ES2912785 T3 ES 2912785T3 ES 18791406 T ES18791406 T ES 18791406T ES 18791406 T ES18791406 T ES 18791406T ES 2912785 T3 ES2912785 T3 ES 2912785T3
- Authority
- ES
- Spain
- Prior art keywords
- tube
- catheter
- patient
- ureteral
- distal end
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title description 42
- 230000010412 perfusion Effects 0.000 title description 9
- 230000006698 induction Effects 0.000 title description 7
- 210000003734 kidney Anatomy 0.000 claims abstract description 185
- 239000012530 fluid Substances 0.000 claims abstract description 119
- 210000000626 ureter Anatomy 0.000 claims abstract description 97
- 210000000244 kidney pelvis Anatomy 0.000 claims abstract description 95
- 230000014759 maintenance of location Effects 0.000 claims abstract description 84
- 239000000463 material Substances 0.000 claims description 34
- 210000001635 urinary tract Anatomy 0.000 claims description 32
- 238000004891 communication Methods 0.000 claims description 14
- 230000001939 inductive effect Effects 0.000 claims description 10
- 210000003932 urinary bladder Anatomy 0.000 description 170
- 210000002700 urine Anatomy 0.000 description 137
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 44
- 210000004369 blood Anatomy 0.000 description 32
- 239000008280 blood Substances 0.000 description 32
- 210000005239 tubule Anatomy 0.000 description 26
- 238000005534 hematocrit Methods 0.000 description 25
- 229940109239 creatinine Drugs 0.000 description 22
- 210000003708 urethra Anatomy 0.000 description 22
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 19
- 239000011734 sodium Substances 0.000 description 19
- 229910052708 sodium Inorganic materials 0.000 description 19
- 241001465754 Metazoa Species 0.000 description 18
- 210000001519 tissue Anatomy 0.000 description 18
- 230000002485 urinary effect Effects 0.000 description 17
- 208000033626 Renal failure acute Diseases 0.000 description 15
- 201000011040 acute kidney failure Diseases 0.000 description 15
- 238000002560 therapeutic procedure Methods 0.000 description 15
- 208000009304 Acute Kidney Injury Diseases 0.000 description 14
- 238000001914 filtration Methods 0.000 description 13
- 238000002637 fluid replacement therapy Methods 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 230000001965 increasing effect Effects 0.000 description 12
- 238000012544 monitoring process Methods 0.000 description 12
- 230000002829 reductive effect Effects 0.000 description 12
- 210000001631 vena cava inferior Anatomy 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- 230000037396 body weight Effects 0.000 description 11
- 230000003907 kidney function Effects 0.000 description 10
- 210000000885 nephron Anatomy 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 206010059484 Haemodilution Diseases 0.000 description 9
- 206010020565 Hyperaemia Diseases 0.000 description 9
- 230000002706 hydrostatic effect Effects 0.000 description 9
- 238000001356 surgical procedure Methods 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 230000009724 venous congestion Effects 0.000 description 9
- 230000006378 damage Effects 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 239000012781 shape memory material Substances 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- 206010019280 Heart failures Diseases 0.000 description 7
- 210000002565 arteriole Anatomy 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- -1 polyethylene Polymers 0.000 description 7
- 230000009103 reabsorption Effects 0.000 description 7
- 230000000638 stimulation Effects 0.000 description 7
- 206010016803 Fluid overload Diseases 0.000 description 6
- 241000282887 Suidae Species 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000004323 axial length Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000004276 hyalin Anatomy 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 206010016807 Fluid retention Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 239000012491 analyte Substances 0.000 description 5
- 238000000429 assembly Methods 0.000 description 5
- 230000000712 assembly Effects 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 210000001736 capillary Anatomy 0.000 description 5
- 230000007850 degeneration Effects 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000005484 gravity Effects 0.000 description 5
- 210000005084 renal tissue Anatomy 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 206010021143 Hypoxia Diseases 0.000 description 4
- 230000009056 active transport Effects 0.000 description 4
- 210000003484 anatomy Anatomy 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 210000004351 coronary vessel Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000000004 hemodynamic effect Effects 0.000 description 4
- 210000000210 loop of henle Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 4
- 230000008855 peristalsis Effects 0.000 description 4
- 230000002572 peristaltic effect Effects 0.000 description 4
- 229920000915 polyvinyl chloride Polymers 0.000 description 4
- 239000004800 polyvinyl chloride Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000012800 visualization Methods 0.000 description 4
- 206010007556 Cardiac failure acute Diseases 0.000 description 3
- 208000004990 Cardiorenal syndrome Diseases 0.000 description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 102000007562 Serum Albumin Human genes 0.000 description 3
- 108010071390 Serum Albumin Proteins 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229910052804 chromium Inorganic materials 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000001926 lymphatic effect Effects 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 3
- 229910001000 nickel titanium Inorganic materials 0.000 description 3
- 210000004197 pelvis Anatomy 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000005086 pumping Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- 230000002407 ATP formation Effects 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 206010041277 Sodium retention Diseases 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229920000249 biocompatible polymer Polymers 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000002665 bowman capsule Anatomy 0.000 description 2
- 208000020832 chronic kidney disease Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000018875 hypoxemia Diseases 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012806 monitoring device Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000005070 sphincter Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- ZHVLGOLHHYJSBZ-QRPNPIFTSA-N (2s)-1-phenylpropan-2-amine;phosphoric acid Chemical compound OP(O)(O)=O.C[C@H](N)CC1=CC=CC=C1 ZHVLGOLHHYJSBZ-QRPNPIFTSA-N 0.000 description 1
- 206010058808 Abdominal compartment syndrome Diseases 0.000 description 1
- 102000008873 Angiotensin II receptor Human genes 0.000 description 1
- 108050000824 Angiotensin II receptor Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020524 Hydronephrosis Diseases 0.000 description 1
- 206010021137 Hypovolaemia Diseases 0.000 description 1
- 208000002623 Intra-Abdominal Hypertension Diseases 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000013276 bronchoscopy Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000013130 cardiovascular surgery Methods 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000013156 embolectomy Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 201000000523 end stage renal failure Diseases 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000002682 general surgery Methods 0.000 description 1
- 210000005086 glomerual capillary Anatomy 0.000 description 1
- 230000001434 glomerular Effects 0.000 description 1
- 210000000585 glomerular basement membrane Anatomy 0.000 description 1
- 230000024924 glomerular filtration Effects 0.000 description 1
- 210000001282 glomerular podocyte Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- DDLIGBOFAVUZHB-UHFFFAOYSA-N midazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NC=C2CN=C1C1=CC=CC=C1F DDLIGBOFAVUZHB-UHFFFAOYSA-N 0.000 description 1
- 229960003793 midazolam Drugs 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000007383 nerve stimulation Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000009057 passive transport Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 238000013310 pig model Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 210000000557 podocyte Anatomy 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 231100000857 poor renal function Toxicity 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000012495 positive regulation of renal sodium excretion Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229960004134 propofol Drugs 0.000 description 1
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 description 1
- 210000000512 proximal kidney tubule Anatomy 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 238000002106 pulse oximetry Methods 0.000 description 1
- 239000003087 receptor blocking agent Substances 0.000 description 1
- 238000012959 renal replacement therapy Methods 0.000 description 1
- 210000002796 renal vein Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000021023 sodium intake Nutrition 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000012384 transportation and delivery Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000004148 unit process Methods 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 230000003202 urodynamic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
- A61M27/008—Implant devices for drainage of body fluids from one part of the body to another pre-shaped, for use in the urethral or ureteral tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2002/047—Urethrae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/73—Suction drainage systems comprising sensors or indicators for physical values
- A61M1/732—Visual indicating means for vacuum pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/78—Means for preventing overflow or contamination of the pumping systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/84—Drainage tubes; Aspiration tips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/84—Drainage tubes; Aspiration tips
- A61M1/87—Details of the aspiration tip, not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
- A61M2210/1082—Kidney
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
- A61M2210/1085—Bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M25/04—Holding devices, e.g. on the body in the body, e.g. expansible
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Ophthalmology & Optometry (AREA)
- External Artificial Organs (AREA)
- Prostheses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762489831P | 2017-04-25 | 2017-04-25 | |
| US201762489789P | 2017-04-25 | 2017-04-25 | |
| US15/687,083 US10926062B2 (en) | 2015-07-20 | 2017-08-25 | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| US15/687,064 US10765834B2 (en) | 2015-07-20 | 2017-08-25 | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| US201815745823A | 2018-01-18 | 2018-01-18 | |
| PCT/US2018/015282 WO2018200052A1 (en) | 2017-04-25 | 2018-01-25 | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2912785T3 true ES2912785T3 (es) | 2022-05-27 |
Family
ID=63918653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18791406T Active ES2912785T3 (es) | 2017-04-25 | 2018-01-25 | Catéteres ureterales y vesicales y métodos de inducción de presión negativa para aumentar la perfusión renal |
Country Status (6)
| Country | Link |
|---|---|
| EP (4) | EP4008372A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7084942B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN110636816A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112019022400A2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2912785T3 (cg-RX-API-DMAC7.html) |
| WO (3) | WO2018200051A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10512713B2 (en) | 2015-07-20 | 2019-12-24 | Strataca Systems Limited | Method of removing excess fluid from a patient with hemodilution |
| US10493232B2 (en) | 2015-07-20 | 2019-12-03 | Strataca Systems Limited | Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function |
| US10765834B2 (en) | 2015-07-20 | 2020-09-08 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| US11229771B2 (en) | 2015-07-20 | 2022-01-25 | Roivios Limited | Percutaneous ureteral catheter |
| US10926062B2 (en) | 2015-07-20 | 2021-02-23 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| WO2017015351A2 (en) | 2015-07-20 | 2017-01-26 | Strataca Systems, LLC | Ureteral and bladder catheters and methods for inducing negative pressure to increase renal perfusion |
| US12064567B2 (en) | 2015-07-20 | 2024-08-20 | Roivios Limited | Percutaneous urinary catheter |
| US11040180B2 (en) | 2015-07-20 | 2021-06-22 | Strataca Systems Limited | Systems, kits and methods for inducing negative pressure to increase renal function |
| US11040172B2 (en) | 2015-07-20 | 2021-06-22 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| US10918827B2 (en) | 2015-07-20 | 2021-02-16 | Strataca Systems Limited | Catheter device and method for inducing negative pressure in a patient's bladder |
| US11541205B2 (en) | 2015-07-20 | 2023-01-03 | Roivios Limited | Coated urinary catheter or ureteral stent and method |
| MX2020002064A (es) * | 2017-08-25 | 2020-10-16 | Roivios Ltd | Bomba permanente para facilitar la extracción de orina del tracto urinario. |
| EP3883630B1 (en) * | 2018-11-21 | 2023-09-27 | Coloplast A/S | An intermittent urinary catheter |
| CN113382756A (zh) * | 2018-11-30 | 2021-09-10 | 斯特拉塔卡系统有限公司 | 涂覆和/或浸渍输尿管导管或支架及其制造方法 |
| PT3921009T (pt) * | 2019-02-08 | 2023-11-09 | Coloplast As | Um cateter urinário |
| EP3718593B1 (en) * | 2019-04-02 | 2022-12-14 | Universität Regensburg - Universitätsklinikum | Transurethral catheter device for bleeding control in pelvic fractures |
| US11628271B2 (en) * | 2019-06-10 | 2023-04-18 | Spinal Singularity, Inc. | Urinary catheter |
| CN113663203B (zh) * | 2020-01-17 | 2023-04-28 | 浙江医高医疗科技有限公司 | 一种改良的输尿管支架 |
| US20210370019A1 (en) * | 2020-05-28 | 2021-12-02 | Strataca Systems Limited | Method of Treatment Using Negative Pressure Renal Therapy and Medicament(s) |
| GB2603124B (en) * | 2021-01-22 | 2024-08-14 | Cambridge Univ Hospitals Nhs Foundation Trust | Vacuum Therapy Devices and Methods |
| JP2024515050A (ja) * | 2021-04-09 | 2024-04-04 | ピュアウィック コーポレイション | 少なくとも１つの管路多孔性材料を含む管路 |
| US12472301B2 (en) | 2021-08-13 | 2025-11-18 | 3Ive Labs, Llc | Negative pressure therapy system and methods |
| CN114404780A (zh) * | 2022-01-24 | 2022-04-29 | 成都维宁生物技术有限公司 | 无囊防漏留置导尿管及其制造方法和用途 |
| CN114558179A (zh) * | 2022-03-04 | 2022-05-31 | 成都莫瑞克生物技术有限公司 | 自开式瓣状导尿管及其制造方法和用途 |
| US20230364322A1 (en) * | 2022-05-10 | 2023-11-16 | Roivios Limited | Wearable Garment for Negative Pressure Therapy |
| CN117282001A (zh) * | 2022-06-17 | 2023-12-26 | 上海交通大学医学院附属仁济医院 | 一种用于泌尿科的多药物涂层抗肿瘤的输尿管支架 |
| WO2024062218A1 (en) * | 2022-09-20 | 2024-03-28 | Convatec Limited | A catheter |
| CN116370805A (zh) * | 2023-04-20 | 2023-07-04 | 山东威高集团医用高分子制品股份有限公司 | 一种输尿管支架及支架放置套装 |
| CN119701112B (zh) * | 2025-02-28 | 2025-06-06 | 复旦大学 | 一种淋巴引流装置 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3397699A (en) * | 1966-05-05 | 1968-08-20 | Gerald C. Kohl | Retaining catheter having resiliently biased wing flanges |
| US5562622A (en) * | 1995-03-20 | 1996-10-08 | Contimed, Inc. | Self-cleansing bladder drainage device |
| US6500158B1 (en) * | 1997-03-26 | 2002-12-31 | The Trustees Of Columbia University In The City Of New York | Method of inducing negative pressure in the urinary collecting system and apparatus therefor |
| US6332892B1 (en) * | 1999-03-02 | 2001-12-25 | Scimed Life Systems, Inc. | Medical device with one or more helical coils |
| US6709465B2 (en) | 1999-03-18 | 2004-03-23 | Fossa Medical, Inc. | Radially expanding ureteral device |
| US6558350B1 (en) * | 2000-06-20 | 2003-05-06 | Applied Medical Resources Corp. | Drainage catheter |
| ES2551521T3 (es) * | 2000-12-11 | 2015-11-19 | Orbusneich Medical, Inc. | Endoprótesis que tiene elementos helicoidales |
| US8506647B2 (en) * | 2002-02-14 | 2013-08-13 | Boston Scientific Scimed, Inc. | System for maintaining body canal patency |
| CN2588940Y (zh) * | 2002-10-31 | 2003-12-03 | 上海富士能高内镜有限公司 | 一种扩张吸引器 |
| WO2006044621A2 (en) * | 2004-10-15 | 2006-04-27 | The Regents Of The University Of California | Improved drainage system |
| US7931630B2 (en) * | 2005-07-05 | 2011-04-26 | C. R. Bard, Inc. | Multi-functional and modular urine collection system |
| WO2007027830A1 (en) * | 2005-08-31 | 2007-03-08 | Vance Products Incorporated | Coaxial dilatation method for stent implantation |
| WO2007065720A2 (en) | 2005-12-09 | 2007-06-14 | Dsm Ip Assets B.V. | Hydrophilic coating composition for urinary catheter |
| US20080255550A1 (en) * | 2006-11-30 | 2008-10-16 | Minos Medical | Systems and methods for less invasive neutralization by ablation of tissue including the appendix and gall bladder |
| US20090105719A1 (en) * | 2007-10-19 | 2009-04-23 | Vance Products Incorporated, D/B/A Cook Urological Incorporated | Precision stent positioner |
| CN100548245C (zh) * | 2007-12-21 | 2009-10-14 | 山东大学 | 微创负压膀胱穿刺造瘘留置装置及其工作方法 |
| EP2349082B1 (en) * | 2008-10-10 | 2021-04-07 | Implantica Patent Ltd. | Implantable device for internal urinary control |
| EP3257484A1 (en) * | 2009-01-18 | 2017-12-20 | Ocon Medical Ltd | Novel intra uterine device |
| CN108392263A (zh) * | 2011-01-19 | 2018-08-14 | 弗拉克泰尔实验室公司 | 用于组织处理的装置与方法 |
| BR112013030183A2 (pt) * | 2011-05-23 | 2017-12-05 | Lazarus Effect Inc | dispositivo médico intervencional para recuperar e assegurrar uma obstrução dentro de um lúmen de vaso, método de assegurar uma obstrução dentro de um vaso, método de preparação de um dispositivo de recuperação, sistema de recuperação de dispositivo médico, para assegurar uma obstrução dentro de um lúmen de vaso e para uso com um cateter configurado para ser navegado através da vasculatura, dispositivo médico intervencional para assegurar um dispositivo de recuperação tendo uma ou mais obstruções localizadas nele para remoção de um corpo e dispositivo de recuperação do stent para se expandir contra um ou mais corpos oclusivos em uma vasculatura |
| US9132040B2 (en) * | 2011-11-17 | 2015-09-15 | Ethicon, Inc. | Dressing device |
| EP2749309B1 (en) * | 2012-12-28 | 2016-04-27 | Cook Medical Technologies LLC | Ion exchange ureteral stent |
| CN106794334B (zh) * | 2014-04-10 | 2020-09-04 | C.R.巴德股份有限公司 | 输尿管支架 |
| EP3160400A4 (en) * | 2014-06-27 | 2018-06-27 | UroGen Pharma Ltd. | A connectable catheter |
| CN204246651U (zh) * | 2014-11-17 | 2015-04-08 | 江苏省人民医院 | 一种易于置换的输尿管支架管 |
| CN205126495U (zh) * | 2015-07-14 | 2016-04-06 | 王洛 | 多分支管肠道套接组件 |
| US10765834B2 (en) | 2015-07-20 | 2020-09-08 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| EP3470107A1 (en) * | 2015-07-20 | 2019-04-17 | Strataca Systems Limited | Ureteral and bladder catheters |
| WO2017015351A2 (en) * | 2015-07-20 | 2017-01-26 | Strataca Systems, LLC | Ureteral and bladder catheters and methods for inducing negative pressure to increase renal perfusion |
| WO2017019974A1 (en) | 2015-07-29 | 2017-02-02 | Renastent Llc | Transformable ureteral stent |
| CN106237417A (zh) * | 2016-05-19 | 2016-12-21 | 黄健 | 一种多功能灌注吸引平台及使用方法 |
| CN106473847A (zh) * | 2016-11-22 | 2017-03-08 | 曹庆杰 | 可降解的膨胀性局部尿路腔内支架系统 |
| ES2911641T3 (es) * | 2017-01-20 | 2022-05-20 | Roivios Ltd | Sistema para remover el exceso de fluido de un paciente con hemodilución |
-
2018
- 2018-01-25 EP EP22152135.4A patent/EP4008372A1/en not_active Withdrawn
- 2018-01-25 JP JP2019557576A patent/JP7084942B2/ja active Active
- 2018-01-25 WO PCT/US2018/015271 patent/WO2018200051A1/en not_active Ceased
- 2018-01-25 CN CN201880027590.3A patent/CN110636816A/zh active Pending
- 2018-01-25 EP EP18791301.7A patent/EP3615125A4/en not_active Withdrawn
- 2018-01-25 JP JP2019557555A patent/JP2020517359A/ja active Pending
- 2018-01-25 BR BR112019022400A patent/BR112019022400A2/pt not_active Application Discontinuation
- 2018-01-25 ES ES18791406T patent/ES2912785T3/es active Active
- 2018-01-25 CN CN201880042008.0A patent/CN110785201A/zh active Pending
- 2018-01-25 EP EP18791406.4A patent/EP3600146B1/en active Active
- 2018-01-25 EP EP18790948.6A patent/EP3614963A4/en active Pending
- 2018-01-25 WO PCT/US2018/015282 patent/WO2018200052A1/en not_active Ceased
- 2018-01-25 WO PCT/US2018/015260 patent/WO2018200050A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018200052A1 (en) | 2018-11-01 |
| EP3600146B1 (en) | 2022-03-02 |
| JP2020517359A (ja) | 2020-06-18 |
| CN110636816A (zh) | 2019-12-31 |
| BR112019022400A2 (pt) | 2020-05-19 |
| EP3614963A4 (en) | 2021-01-13 |
| EP4008372A1 (en) | 2022-06-08 |
| EP3615125A4 (en) | 2021-01-20 |
| JP2020517361A (ja) | 2020-06-18 |
| WO2018200051A8 (en) | 2018-12-27 |
| EP3600146A1 (en) | 2020-02-05 |
| JP7084942B2 (ja) | 2022-06-15 |
| EP3615125A1 (en) | 2020-03-04 |
| EP3614963A1 (en) | 2020-03-04 |
| CN110785201A (zh) | 2020-02-11 |
| WO2018200050A1 (en) | 2018-11-01 |
| EP3600146A4 (en) | 2020-04-15 |
| WO2018200051A1 (en) | 2018-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2912785T3 (es) | Catéteres ureterales y vesicales y métodos de inducción de presión negativa para aumentar la perfusión renal | |
| US12023459B2 (en) | Negative pressure therapy system | |
| US11904113B2 (en) | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion | |
| ES2911641T3 (es) | Sistema para remover el exceso de fluido de un paciente con hemodilución | |
| US10512713B2 (en) | Method of removing excess fluid from a patient with hemodilution | |
| US11918754B2 (en) | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion | |
| US11752300B2 (en) | Catheter device and method for inducing negative pressure in a patient's bladder |